RGS11 Antibodies

Santa Cruz Biotechnology features a diverse variety of RGS11 monoclonal antibodies for research focused on understanding RGS11 protein function. RGS11 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). RGS11, or Regulator of G Protein Signaling 11, plays a central role in modulating G protein-coupled receptor signaling pathways, which are essential for numerous physiological processes. By regulating the activity of G proteins, RGS11 influences cellular responses to hormones and neurotransmitters, making it a key player in signal transduction. Understanding RGS11 function is vital for elucidating its implications in various diseases, including cancer and neurological disorders. RGS11 monoclonal antibodies enable precise detection and characterization of RGS11 expression patterns and interactions. Researchers can effectively investigate G protein signaling mechanisms and their impact on cellular function. RGS11 monoclonal antibodies from Santa Cruz Biotechnology support scientists worldwide in advancing our understanding of signal transduction pathways and their role in human health.